Histogen
(NASDAQ:HSTO)
$1.02
-0.01[-0.97%]
At close: Nov 30(Delayed 15-Minutes)
Get Real Time Here
$1.05
0.0300[2.94%]
After Hours: 4:56PM EDT
Day Range0.99 - 1.0352 Wk Range0.13 - 11.6Open / Close1 / 1.02Float / Outstanding4.1M / 4.3M
Vol / Avg.33.7K / 255.3KMkt Cap4.4MP/E-50d Avg. Price1.24
Div / Yield-Payout Ratio-Total Float4.1MEPS-1.01

Histogen Stock (NASDAQ:HSTO), Quotes and News Summary

Histogen Stock (NASDAQ: HSTO) stock price, news, charts, stock research, profile.

Loading...
Day Range0.99 - 1.0352 Wk Range0.13 - 11.6Open / Close1 / 1.02Float / Outstanding4.1M / 4.3M
Vol / Avg.33.7K / 255.3KMkt Cap4.4MP/E-50d Avg. Price1.24
Div / Yield-Payout Ratio-Total Float4.1MEPS-1.01
Globe Newswire - Jun 1, 2022, 4:00PM
Globe Newswire - Mar 23, 2022, 8:00AM
Globe Newswire - Dec 16, 2021, 8:00AM
InvestorsObserver - Nov 16, 2022, 12:55PM
InvestorsObserver - Nov 14, 2022, 5:58AM
InvestorsObserver - Nov 10, 2022, 5:47AM
InvestorsObserver - Sep 28, 2022, 6:59AM
InvestorsObserver - Sep 15, 2022, 6:43AM
InvestorsObserver - Sep 1, 2022, 11:49AM
InvestorsObserver - Aug 30, 2022, 6:53AM
InvestorsObserver - Aug 23, 2022, 7:09AM
InvestorsObserver - Aug 22, 2022, 8:33AM
InvestorsObserver - Aug 18, 2022, 6:51AM
InvestorsObserver - Aug 15, 2022, 10:42AM
InvestorsObserver - Aug 12, 2022, 1:31PM
InvestorsObserver - Aug 5, 2022, 7:32AM
InvestorsObserver - Aug 4, 2022, 7:17AM
InvestorsObserver - Jul 13, 2022, 6:52AM
InvestorPlace - Jul 12, 2022, 11:41AM
InvestorPlace - Jul 12, 2022, 11:24AM
InvestorsObserver - Jul 12, 2022, 6:47AM
Sector: Health Care.Industry: Biotechnology
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platform and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.

Earnings

see more
Q3 2022Est.ActualSurprise
EPS-1.260-1.010 0.2500
REV5.000K
Q2 2022Est.ActualSurprise
EPS-1.800-1.550 0.2500
REV5.000K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target
Q

How do I buy Histogen (HSTO) stock?

A

You can purchase shares of Histogen (NASDAQ: HSTO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Histogen's (HSTO) competitors?

Q

What is the target price for Histogen (HSTO) stock?

A

The latest price target for Histogen (NASDAQ: HSTO) was reported by HC Wainwright & Co. on Tuesday, March 29, 2022. The analyst firm set a price target for 1.50 expecting HSTO to rise to within 12 months (a possible 47.06% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Histogen (HSTO)?

A

The stock price for Histogen (NASDAQ: HSTO) is $1.02 last updated Today at November 30, 2022, 9:00 PM UTC.

Q

Does Histogen (HSTO) pay a dividend?

A

There are no upcoming dividends for Histogen.

Q

When is Histogen (NASDAQ:HSTO) reporting earnings?

A

Histogen’s Q3 earnings are confirmed for Thursday, November 10, 2022.

Q

Is Histogen (HSTO) going to split?

A

There is no upcoming split for Histogen.

Q

What sector and industry does Histogen (HSTO) operate in?

A

Histogen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.